GLENMARK PHARMACEUTICALS LTD. - Glenmark receives final ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5 mcg and 1mg/ 5mcg
07 Apr 2015
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated April 07, 2015, titled "Glenmark receives final ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5 mcg and 1mg/5 mcg.".
Source:
BSE India